Soldiers in two of the infected countries deployed today to try to stem further spread of the virus.
Even if the experimental drug ZMapp is manufactured in large quantities, its ability to treat Ebola is unproven and furthermore no commitment has been publicly made to provide it to Africa.
The health minister of Nigeria, one of the four countries where Ebola has broken out, told a news conference in Washington that he had asked the US Centers for Disease Control and Prevention about access to the drug. But a CDC spokesman said yesterday "there are virtually no doses available."
"We don't even know if it works," he stressed.
President Barack Obama, who hosted an Africa summit this week, pledged to help "nip as early as possible any additional outbreaks of the disease.
"And then during the course of that process, I think it's entirely appropriate for us to see if there are additional drugs or medical treatments that can improve the survivability of what is a very deadly and obviously brutal disease, Obama said yesterday.
President Ellen Johnson Sirleaf declared a national state of emergency, and officials said today that no one with a fever would be allowed in or out of the country.
In neighboring Sierra Leone, military forces also deployed as part of "Operation Octopus" which officials said was aimed at preventing "the unauthorized movement of Ebola-infected persons."
While the outbreak has now reached four countries across West Africa, Liberia and Sierra Leone account for more than 60 percent of the deaths, according to the World Health Organization. The outbreak that emerged in March has claimed at least 932 lives.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
